Optimeos Life Sciences is a biotechnology company that enables the use of biologics, peptides, and RNA to treat diseases.
Optimeos Life Sciences's investors include National Science Foundation, NJEDA, Hatch Biofund Management.
Optimeos Life Sciences is headquartered in Princeton, United States.
Optimeos Life Sciences is a biotechnology company that enables the use of biologics, peptides, and RNA to treat diseases.
Optimeos Life Sciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Optimeos Life Sciences — Funding & Investors." VCBacked, June 25, 2026, https://www.vcbacked.co/company/optimeos-life-sciences. Accessed November 13, 2026.
VCBacked. (2026). Optimeos Life Sciences — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/optimeos-life-sciences
{{cite web |title=Optimeos Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/optimeos-life-sciences |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Optimeos Life Sciences? Request a listing update